WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2006013602) COMPOSITION CONTAINING STATINS AND OMEGA-3 FATTY ACIDS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2006/013602    International Application No.:    PCT/IT2005/000414
Publication Date: 09.02.2006 International Filing Date: 19.07.2005
IPC:
A61K 31/202 (2006.01), A61K 31/366 (2006.01), A61K 31/122 (2006.01), A61K 31/05 (2006.01), A61K 31/045 (2006.01), A61K 31/175 (2006.01), A61K 33/04 (2006.01), A61K 33/30 (2006.01), A61K 47/00 (2006.01), A61P 3/10 (2006.01), A61P 3/04 (2006.01), A61P 3/06 (2006.01), A61P 9/12 (2006.01), A61P 9/00 (2006.01)
Applicants: SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A. [IT/IT]; Viale Shakespeare, 47, I-00144 Roma RM (IT) (For All Designated States Except US).
CAVAZZA, Claudio [IT/IT]; (IT) (For US Only)
Inventors: CAVAZZA, Claudio; (IT)
Agent: SPADARO, Marco et al.; Cavattoni-Raimondi, Viale dei Parioli, 160, I-00197 Roma (IT)
Priority Data:
RM2004A000395 03.08.2004 IT
Title (EN) COMPOSITION CONTAINING STATINS AND OMEGA-3 FATTY ACIDS
(FR) COMPOSITION CONTENANT DES STATINES ET DES ACIDES GRAS Ω3
Abstract: front page image
(EN)A combination is described comprising at least one omega-3 fatty acid, optionally esterified or salified, at least one statin, Coenzyme Q10, resveratrol, at least one policosanol, pantethine, selenium, and zinc. This combination is endowed with a synergistic effect and is useful in the treatment of disease forms due to insulin resistance and in cardiovascular diseases.
(FR)Cette invention décrit une combinaison d’au moins un acide gras Ω3, éventuellement estérifié ou salifié, au moins une statine, une coenzyme Q10, le resvératrol, au moins du policosanol, la panthénine, le sélénium et du zinc. Cette combinaison est riche en effet synergique et est utile dans le traitement des maladies liées à une résistance à l’insuline et dans des maladies cardiovasculaires.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SM, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)